Search NLS News

The Board of Directors of SciBase has decided to carry out a capital raise totaling approximately SEK 81.8 million.

The company has announced a capital investment in the United States focused on expanding its research and manufacturing footprint by the end of 2026.

The Karolinska ATMP Centre is a joint venture between Karolinska Institutet and Karolinska University Hospital tasked with consolidating all ATMP operations based on cells, genes or tissues to enhance the development and implementation of cell, gene and tissue therapies.

ALK has entered into a strategic license agreement with US-based ARS Pharmaceuticals.

The Knut and Alice Wallenberg Foundation allocates an additional SEK 600 million for data-driven life science.

Leon Wang, Executive Vice President International and AstraZeneca China President, is cooperating with an ongoing investigation by Chinese authorities.

Four months after XNK Therapeutics, located in Huddinge, Sweden, declared bankruptcy, the clinical-stage biotechnology company’s building and physical assets were sold and the lease agreement transferred to BioLamina. 

Biotech talent in production is in high demand and Anocca is taking a creative approach to workforce development: investing in motivated young people through in-house training and education.

Thioredoxin Systems (TXN Systems) has announced the close of a Series A financing round to support the development of EbsArgent, the company's first-in-class bactericidal antibiotic for urinary tract infections (UTIs) caused by antibiotic-resistant bacteria.

The EIC Scaling Club is an accelerators and features more than 120 of the EU’s most innovative deep tech scaleups.